SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Eloxx Pharmaceuticals, Inc. – ‘8-K’ for 9/14/22

On:  Thursday, 9/15/22, at 8:07am ET   ·   For:  9/14/22   ·   Accession #:  1104659-22-100245   ·   File #:  1-31326

Previous ‘8-K’:  ‘8-K’ on / for 8/15/22   ·   Next:  ‘8-K’ on 10/14/22 for 10/11/22   ·   Latest:  ‘8-K’ on 3/29/24 for 3/25/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 9/15/22  Eloxx Pharmaceuticals, Inc.       8-K:7,8,9   9/14/22   12:3.5M                                   Toppan Merrill/FA

Current Report   —   Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     36K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML     20K 
 3: EX-99.2     Miscellaneous Exhibit                               HTML     21K 
 7: R1          Cover                                               HTML     46K 
10: XML         IDEA XML File -- Filing Summary                      XML     12K 
 8: XML         XBRL Instance -- tm2225930d1_8k_htm                  XML     15K 
 9: EXCEL       IDEA Workbook of Financial Reports                  XLSX      8K 
 5: EX-101.LAB  XBRL Labels -- elox-20220914_lab                     XML     97K 
 6: EX-101.PRE  XBRL Presentations -- elox-20220914_pre              XML     64K 
 4: EX-101.SCH  XBRL Schema -- elox-20220914                         XSD     12K 
11: JSON        XBRL Instance as JSON Data -- MetaLinks               25±    33K 
12: ZIP         XBRL Zipped Folder -- 0001104659-22-100245-xbrl      Zip     32K 




        
Filing Submission 0001104659-22-100245 – SGML Text

Original SGML Text submitted by:  Toppan Merrill/FA  (as Filing Agent) 

To view the SGML, please refresh
Refresh emoji
this page.


Top

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., May 15, 7:24:46.4am ET